Cleared Traditional

K961874 - STORZ DP5100 ANTERIOR COLLECTION CASSET...

K961874 is the FDA 510(k) clearance for STORZ DP5100 ANTERIOR COLLECTION CASSET... by Storz Instrument Co.. It is a Class 2 Ophthalmic device (product code HQC) cleared through the Traditional 510(k) pathway after a 83-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1996
Decision
83d
Days
Class 2
Risk

K961874 is an FDA 510(k) clearance for the STORZ DP5100 ANTERIOR COLLECTION CASSETTE PACK. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Storz Instrument Co. (St. Louis, US). The FDA issued a Cleared decision on August 6, 1996 after a review of 83 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Storz Instrument Co. devices

Submission Details

510(k) Number K961874 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 15, 1996
Decision Date August 06, 1996
Days to Decision 83 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
27d faster than avg
Panel avg: 110d · This submission: 83d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 112
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K961874.
STORZ D7116 MICROVIT VITRECTOMY CUTTER EXTENSION
K960003 · Storz Instrument Co. · Aug 1996
STORZ D4600 AIR EXCHANGE LINE PACK
K962131 · Storz Instrument Co. · Aug 1996
STORZ DP5200 IRRIGATION ADDMINISTRATION SET PACK
K961831 · Storz Instrument Co. · Aug 1996
STORZ DP4600 ANTERIOR INTRAOCULAR PRESSURE CONTROL PACK
K961820 · Storz Instrument Co. · Jul 1996
STORZ PREMIERE II MICROSURGICAL SYSTEM (CX SERIES)
K961310 · Storz Instrument Co. · Jun 1996
SYNERGIST POWER PACK
K960414 · Chiron Vision Corp. · Apr 1996